T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.19% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 10.74% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Fulcrum Therapeutics
FULC
$283M
| $596K | ﹤0.01% |
25,205
-109,550
| -81% | -$1.55M |
|
2252
Axsome Therapeutics
AXSM
$11.2B
| $595K | ﹤0.01% |
14,382
+4,068
| +39% | +$126K |
|
2253
G-III Apparel Group
GIII
$1.43B
| $594K | ﹤0.01% |
21,961
+2,294
| +12% | +$62.4K |
|
2254
Amdocs
DOX
$6.23B
| $590K | ﹤0.01% |
7,178
+1,751
| +32% | +$137K |
|
2255
8x8 Inc
EGHT
$303M
| $590K | ﹤0.01% |
46,881
+9,678
| +26% | +$134K |
|
2256
SelectQuote
SLQT
$126M
| $590K | ﹤0.01% |
211,484
-939,844
| -82% | -$4.53M |
|
|
ACRE
2257
Ares Commercial Real Estate
ACRE
$264M
| $587K | ﹤0.01% |
37,802
-1,135
| -3% | -$16.7K |
|
2258
Ezcorp Inc
EZPW
$1.76B
| $586K | ﹤0.01% |
97,084
-42,931
| -31% | -$268K |
|
2259
First Financial Corp
THFF
$975M
| $585K | ﹤0.01% |
13,526
-1,424
| -10% | -$64.4K |
|
2260
ATN International
ATNI
$491M
| $583K | ﹤0.01% |
14,612
+1,085
| +8% | +$40.6K |
|
|
ADAM
2261
Adamas Trust
ADAM
$907M
| $580K | ﹤0.01% |
39,721
+2,136
| +6% | +$31.2K |
|
|
VISN
2262
Vistance Networks Inc
VISN
$2.62B
| $579K | ﹤0.01% |
73,459
+11,725
| +19% | +$107K |
|
|
FOCS
2263
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $578K | ﹤0.01% |
12,631
+1,797
| +17% | +$90.2K |
|
2264
Vicor
VICR
$10.4B
| $574K | ﹤0.01% |
8,140
+434
| +6% | +$39K |
|
|
QUOT
2265
DELISTED
Quotient Technology Inc
QUOT
| $572K | ﹤0.01% |
89,698
+5,512
| +7% | +$36.9K |
|
|
HSII
2266
DELISTED
Heidrick & Struggles
HSII
| $570K | ﹤0.01% |
14,394
+444
| +3% | +$18.8K |
|
2267
iShares MSCI Saudi Arabia ETF
KSA
$625M
| $570K | ﹤0.01% |
+12,000
| New | +$546K |
|
|
DVAX
2268
DELISTED
Dynavax Technologies
DVAX
| $565K | ﹤0.01% |
52,098
-20,231
| -28% | -$246K |
|
2269
Healthcare Services Group
HCSG
$1.45B
| $565K | ﹤0.01% |
30,414
+1,683
| +6% | +$29K |
|
2270
Interface
TILE
$2.24B
| $564K | ﹤0.01% |
41,586
+8,952
| +27% | +$123K |
|
|
NWLI
2271
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $563K | ﹤0.01% |
2,675
+960
| +56% | +$205K |
|
2272
Hovnanian Enterprises
HOV
$799M
| $562K | ﹤0.01% |
9,502
+2,121
| +29% | +$192K |
|
2273
Modine Manufacturing
MOD
$10.8B
| $562K | ﹤0.01% |
62,327
+1,033
| +2% | +$10.2K |
|
2274
Mastech Digital
MHH
$95.3M
| $560K | ﹤0.01% |
30,284
| – | – |
|
2275
Nektar Therapeutics
NKTR
$2.57B
| $560K | ﹤0.01% |
6,932
+669
| +11% | +$99K |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.